John J. Sperzel III, Chairman and CEO at T2 Biosystems, Inc. (TTOO), sold 9,773 shares at $0.59 ($6K) on 2023-02-28, disclosed to the SEC on 2023-03-09.
Scheduled sale ($6k) by Chairman and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.65 | 6,875 | $4K | 72.3% |
| 2 | $0.59 | 2,898 | $2K | 27.7% |
| Total | $0.63 avg | 9,773 | $6K | 100% |